An Open-Label, Single-Arm, Pharmacokinetic and Safety Study of Likmez® (Metronidazole Oral Suspension) in Pediatric Patients Aged 12 Months to <4 Years With Anaerobic Bacterial Infection

Inclusion Criteria: * Age between ≥ 12 months and \< 4 years till the time of dosing in the study * Sufficient venous access to permit cannulation for required blood sample collection. * Ability to swallow oral liquids. * Clinical diagnosis with suspected or culture-confirmed anaerobic bacterial infection with pathogens known to be sensitive to metronidazole and requiring treatment for any of the below mentioned infections: 1. Septicaemia and Bacteraemia 2. Intra-abdominal infections (including peritonitis, intra-abdominal abscess, and liver abscess) 3. Bone and joint infections (inclu…